Exciting new treatment options may be on the horizon for hemophilic arthropathy (HA) or permanent joint disease as a long-term consequence of repeated hemarthrosis. At the Wednesday morning plenary, Carl Blobel, Weill Medical College of Cornell University, USA, posed the question, “With blood in the joint what happens next?” Recurrent … Read more
↧
